Descrição

Body weight and general health monitoring data for APP/PS1 transgenic mice during the 30-day treatment period with HE-Et and HE-My, confirming tolerability of the lion's mane extract interventions.

Figure 3

Chart

Source Paper

Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice.

Journal of biomedical science (2016)

PMID: 27350344

DOI: 10.1186/s12929-016-0266-z

Cite This Figure

![Figure 3: Body weight and general health monitoring data for APP/PS1 transgenic mice during the 30-day treatment period with HE-Et and HE-My, confirming tolerability of the lion's mane extract interventions.]()

> Source: Tzeng Tsai-Teng et al. "Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease." *Journal of biomedical science*, 2016. PMID: [27350344](https://pubmed.ncbi.nlm.nih.gov/27350344/)

<figure>
  <img src="" alt="Body weight and general health monitoring data for APP/PS1 transgenic mice during the 30-day treatment period with HE-Et and HE-My, confirming tolerability of the lion's mane extract interventions." />
  <figcaption>Figure 3. Body weight and general health monitoring data for APP/PS1 transgenic mice during the 30-day treatment period with HE-Et and HE-My, confirming tolerability of the lion's mane extract interventions.<br>  Source: Tzeng Tsai-Teng et al. "Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease." <em>Journal of biomedical science</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27350344/">27350344</a></figcaption>
</figure>

Evidências Relacionadas

Lion's Mane Mushroom para Mild Cognitive Impairment (MCI)

Nota B · 6 estudos

Lion's Mane Mushroom para Brain Fog

Nota C · 4 estudos